All posts by: Michael Zand

ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to Evotec – Business Wire (press release)

Business Wire (press release)ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to EvotecBusiness Wire (press release)“This license enables them to further expand their service offering in the CRISPR gene-editing space.” Evotec uses the CRISPR/Ca… Continue reading

Vascugen licenses stem cell tech for blood vessel regeneration developed at IU School of Medicine – IU Newsroom

IU NewsroomVascugen licenses stem cell tech for blood vessel regeneration developed at IU School of MedicineIU NewsroomThe company holds the rights to an exclusive, worldwide license to a broad patent portfolio encompassing the repair, regeneration and… Continue reading

Bismarck clinic agrees to repay patients $20K, discontinue stem cell injections – Bismarck Tribune

Bismarck clinic agrees to repay patients $20K, discontinue stem cell injections Bismarck Tribune Following an investigation by the North Dakota Attorney General’s office, a Bismarck stem cell clinic has agreed to pay nearly $20,000 in consumer refunds and discontinue stem cell injections not approved by the U.S. Food and Drug Administration. An …